| CQCT |
PRIMARY CONTAINER TYPE |
VIAL |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
60.000 MICROGRAMS BIOTIN ACTIVE INGREDIENT AND 5.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 5.000 MICROGRAMS ERGOCALCIFEROL ACTIVE INGREDIENT AND 4.000 MILLIGRAMS PYRIDOXINE ACTIVE INGREDIENT AND 100.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 1.000 MILLIGRAMS RETINOL ACTIVE INGREDIENT AND 3.600 MILLIGRAMS RIBOFLAVIN PHOSPHATE SODIUM ACTIVE INGREDIENT AND 10.000 MILLIGRAMS DL-ALPHA-TOCOPHERYL ACETATE ACTIVE INGREDIENT AND 15.000 MILLIGRAMS DEXPANTHENOL ACTIVE INGREDIENT AND 400.000 MICROGRAMS FOLIC ACID ACTIVE INGREDIENT AND 40.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 3.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
25 |
| FEAT |
SPECIAL FEATURES |
CONTAIN STABILIZERS; TO BE RECONSTITUTED WITH 5 ML OF STERILE WATER FORINJECTION USP BEFORE ADDING TO IV INFUSION FLUID |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
10.000 MILLILITERS AFTER RECONSTITUTION |
| AGXW |
PHYSICAL FORM |
POWDER,LYOPHILIZED |
| CBBL |
FEATURES PROVIDED |
DILUENT AND STERILE |
| PKTY |
UNIT PACKAGE TYPE |
BOX |
| CSGS |
ADMINISTRATION |
INTRAVENOUS |